US3055907A - Acyl benzimidazoles and method of preparing same - Google Patents

Acyl benzimidazoles and method of preparing same Download PDF

Info

Publication number
US3055907A
US3055907A US15518A US1551860A US3055907A US 3055907 A US3055907 A US 3055907A US 15518 A US15518 A US 15518A US 1551860 A US1551860 A US 1551860A US 3055907 A US3055907 A US 3055907A
Authority
US
United States
Prior art keywords
benzimidazole
thiazolyl
benzimidazoles
mixture
acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US15518A
Inventor
Horace D Brown
Lewis H Sarett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE599143D priority Critical patent/BE599143A/xx
Priority to US2856A priority patent/US3017415A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to US15518A priority patent/US3055907A/en
Priority to DEM45481A priority patent/DE1235321B/en
Priority to GB20378/60A priority patent/GB948635A/en
Priority to ES0263822A priority patent/ES263822A1/en
Priority to FR849060A priority patent/FR1423609A/en
Priority to CH49061A priority patent/CH423789A/en
Priority to CH1531865A priority patent/CH423793A/en
Priority to CH1531665A priority patent/CH423791A/en
Priority to DK19761AA priority patent/DK107167C/en
Priority to CH1531765A priority patent/CH423792A/en
Priority to CH1531565A priority patent/CH423790A/en
Priority to SE436/61A priority patent/SE310883B/xx
Application granted granted Critical
Publication of US3055907A publication Critical patent/US3055907A/en
Priority to OA51102A priority patent/OA00999A/en
Priority to CY30965A priority patent/CY309A/en
Priority to MY196575A priority patent/MY6500075A/en
Priority to SE11797/67A priority patent/SE320977B/xx
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Definitions

  • This invention relates to new compounds useful against helminthiasis. It relates generally to new l-acyl benzimidazoles. More particularly, it relates to 1-acyl benzimidazoles having at the 2 position a heterocyclic radical containing nitrogen and sulfur. It is concerned also with methods of making such compounds from the corresponding unacylated benzimidazoles.
  • the infection known as helminthiasis involves infestation of the animal body, and particularly the gastrointestinal tract, with various species of parasitic worms. It is a very widespread and serious disease, and the methods heretofore available for its treatment and prevention have not been entirely satisfactory. It is an object of this invention to provide a group of substituted l-acyl benzimidazoles which are eifective in controlling helminthiasis, and which lack many of the objectionable features of the known anthelmintics.
  • benzimidazoles having an acyl radical at the 1 position of the benzimidazole ring nucleus and a heterocyclic radical containing nitrogen and sulfur at the 2 position thereof possess a significant degree of anthelmintic ac tivity and may be effectively employed in the treatment and/or prevention of helminthiasis. It is one object of the invention to provide such compounds. It is a more particular object to provide benzimidazoles substituted at the 1 position with an acyl radical and at the 2 position with a five-membered heterocyclic radical containing nitrogen and sulfur. A further object is provision of a method of synthesizing such compounds. Still other objects will become apparent from the following description of the invention.
  • the new compounds of our invention have the general structural formula the point of attachment to the benzimidazole nucleus may be at any one of the three carbon atoms of the heterocyclic ring, as indicated by the broken lines in the partial structures:
  • R is a thiadiazolyl group containing two nitrogen atoms and one sulfur atom in the ring
  • the radical may be attached to the benzimidazole at either of the two groups at the 5 and/or 6 positions.
  • the preferred substituents although ethyl, propyl and sim- 3,055,907 Patented Sept. 25, 1962 carbon atoms in a 1,2,3-thiadiazole or a 1,2,4-thiadiazole:
  • the heterocyclic radical may, if desired, be further substituted at a carbon atom with a lower hydrocarbon group such as a lower alkyl radical, the only limitation in this regard being that imposed by the availability of the substituted thiazoles, isothiazoles or thiadiazoles to be used as starting materials.
  • 2-(2'-thiazolyl)-benzirnidazoles having a lower alkyl group at the 4 position of the thiazole ring and the 2-(5-isothiazolyl)-benzimidazoles having a lower alkyl group at the 3 position of the isothiazole ring such as 2-(4'methyl-2'-thiazolyl)-benzimidazole and 2 (3' methyl 5 isothiazolyl) benzimidazole are illustrative of this aspect of the invention.
  • R in Formula I above may be hydrocarbonyl radicals such as methyl, ethyl, propyl, butyl, phenyl, benzyl and phenylethyl.
  • the N-1 substituent is a lower alkanoyl group
  • the 2 substituent is a Z-thiazolyl or 4-thi'azolyl radical.
  • the six-membered ring of the benzimidazole nucleus may also be substituted, as with lower alkyl Methyl groups are ilar lower alkyl radicals may, of course, be employed.
  • the so-called pseudo-alkyl radicals, such as a trifluoromethyl substituent, may also be present at the 5 or 6 positions of the benzimidazole.
  • the 1 lower alkanoyl 2 thiazolyl benzimidazoles wherein the point of attachment of the thiazolyl radical to the benzimidazole moiety is either the 2 or 4 position of the thiazole ring, represent the preferred compounds of the invention.
  • These substances and the other l-acyl- 2-substituted benzimidazoles described herein are prepared by acylation of an alkali metal salt of a Z-R-benzimidazole as illustrated by the flow diagram:
  • R is a five-membered heterocyclie radical containing nitrogen and sulfur
  • R is a hydrocarbonyl radical
  • R and R are hydrogen or lower alkyl (or pseudo-alkyl)
  • M is an alkali metal
  • X is chlorine or bromine.
  • the process is carried out by first converting a 2-R- benzimidazole, where R is as above defined, to an alkali metal salt. It is preferred to form the sodium salt by reacting or intimately contacting the benzimidazole with sodium hydride in a suitable solvent medium. Satisfactory results are obtained when a slight molar excess of sodium hydride is employed, although equimolar quantities of benzimidazole and sodium hydride may be used if desired. The reaction is conveniently brought about by warming the reactants at slightly elevated temperatures, but this is not essential and room temperature is satisfactory.
  • the novel 1-acyl-2-R benzimidazoles of the invention are obtained by contacting the benzimidazole alkali metal salt with an acyl halide such as acetyl chloride, acetyl bromide, propionyl chloride, butyryl chloride, valeroyl bromide, benzoyl chloride, phenylacetyl chloride and the like.
  • an acyl halide such as acetyl chloride, acetyl bromide, propionyl chloride, butyryl chloride, valeroyl bromide, benzoyl chloride, phenylacetyl chloride and the like.
  • the acyl halide is added directly to a solution or suspension of the benzimidazole salt in an inert solvent, and the acylation reaction allowed to proceed at temperatures of room temperature up to about 100 C. Reaction temperatures in the range of 5075 C. are preferred.
  • the solvent employed as the reaction medium is preferably a hydro
  • the l-acyl benzirnidazoles thus formed are recovered from the reaction mixture by techniques known in the art, such as removal of the organic solvent and crystallization of the residual solid from solvents such as ether or mixtures of ether with other solvents.
  • the 1-acyl-2-substituted benzimidazoles described herein have a high degree of anthelmintic activity with a low incidence of undesirable side effects. They are therefore useful in the treatment and/or prevention of helminthiasis, a parasitic disease which causes widespread and often serious infection in domesticated animals such as swine, ruminants such as cattle and sheep, and in man.
  • the compounds of this invention are normally used, in treating helminthiasis, in unit dosage forms such as tablets, capsules, powders and the like wherein the active ingredient is intimately admixed with a suitable inert carrier.
  • the compounds are mixed with a non-toxic edible carrier to form a feed supplement which is then incorporated in the animal feed in the desired concentration, or they may be administered in unit dosage forms which, in the case of large domesticated animals, take the form of boluses, or in the form of a liquid drench.
  • a feed supplement which is then incorporated in the animal feed in the desired concentration
  • they may be administered in unit dosage forms which, in the case of large domesticated animals, take the form of boluses, or in the form of a liquid drench.
  • water soluble salts or a dispersable, wettable powder containing the 2-heterocyclic benzimidazole may be added to the drinking water of the animals.
  • EXAMPLE 1 1-Acetyl-2-(4'-Thiazolyl) -Benzimidazole g. (0.1 M) of 2-(4-thiazolyl)-benzimidazole is dissolved in a mixture of 500 ml. of toluene and 150 ml. of dimethylforrnamide. Traces of water are removed by distilling ml. of toluene from the mixture. 3.6 g. of sodium hydride (0.15 M) as a 50% emulsion in oil is suspended in 10 ml. of toluene and the mixture added to the benzimidazole solution at a temperature of about 60 C. The sodium hydride addition is carried out portionwise. The resulting mixture is stirred at 60 C.
  • EXAMPLE 2 1-Benz0yl-2-(4-Thiaz0lyl) -Benzimidaz0le 20 g. of 2-(4-thiazolyl)-benzimidazole in a mixture of 400 ml. of benzene and 175 ml. of dimethylformamide is treated at 60 C. with 3.6 g. of sodium hydride. The sodium hydride is added as a 50% emulsion in oil mixed with 10 ml. of benzene. The addition is carried out slowly and the mixture heated with stirring at 60 C. for 45 minutes after completion of the sodium hydride addition. At the end of this time, 14 g. of benzoyl chloride is added slowly at a temperature of 60 C.
  • 1-phenylacety1-2-(4-thiazolyl)-5-methyl benzimidazole and 1-phenylacetyl-2-(4-methyi-2-thiazolyl) benzimidazole are prepared in like fashion by reacting phenylacetyl bromide with 2-(4-thiazolyl)-5-methyl benzimidazole and 2-(4-methyl-2'-thiazo1yl)-benzimidazole respectively.
  • the 2-heterocyc1ic henzimidazoles employed as starting material in making the compounds of this invention are prepared by reacting together o-phenylenediamine and a heterocyclic earboxylic acid (Or derivative thereof) in polyphosphoric acid.
  • the process is carried out at elevated temperatures, and preferably at temperatures of about 150-300 C.
  • the optimum reaction time and temperature will, of course, depend to some extent on the particular reactants being employed, but in general good yields of the desired compounds are obtained by conducting the process at temperatures of about 175 to about 275 C. for from 2 to 6 hours.
  • the heterocyclic reactant is one that tends to decompose at elevated temperatures, e.g.
  • thiazole-Z-carboxamide is preferred over thiazole-Z-carboxylic acid as starting material in the synthesis of 2-(2'-thiazolyl)-benzimidazole since the free acid tends to decompose to thiazole itself at reaction temperature. It is preferred to employ substantially equimolar amounts of the heterocyclic compound and the diamine, and from about 20 parts by weight of polyphosphoric acid per part of heterocycle, although it will be appreciated by those skilled in this art that the relative amount of reactants is not a critical feature of the invention.
  • the desired 2-substituted benzimidazoles are recovered by cooling the reaction mixture and diluting it with Water.
  • benzimidazoles do not crystallize readily under these conditions, they are precipitated by neutralizing the quenched mixture with a base such as ammonium hydroxide, an alkali metal hydroxide or an alkali metal carbonate.
  • a base such as ammonium hydroxide, an alkali metal hydroxide or an alkali metal carbonate.
  • 2-(4'-thiazolyl)-benzimidazole pre cipitates. It is filtered, washed with water, and dried in air, M.P. 296-298 C.
  • This product is extracted with boiling ethanol. Some benzene is added to the extract and the solution boiled to remove traces of water. On concentration of the solution to a small volume and cooling, 2 -(4-thiazolyl)-benzirnidazole crystallizes, M.P. 301-302 C.
  • the solid is washed with water, sodium bicarbonate solution to insure neutrality and dried in air.
  • the 2-[3-(1',2',5-thiadiazolyl)]-benzimidazole is then recrystallized from ethyl acetate solution with a decolorizing charcoal treatment, M.P. 268-70 C. (sublimation 240). Recrystallization from ethyl acetate raises the M.P. to 272-274 C.
  • a benzimidazole having the formula wherein R is a five-membered heterocyclic radical selected from the class consisting of thiazolyl, thiadi-azolyl and isothiazolyl rings wherein one carbon atom of said ring is attached to the benzimidazole ring, and the remaining car- References Cited in the file of this patent UNITED STATES PATENTS 2,483,392 Meyer et al Oct. 4, 1949

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

United States Patent Ofitice 3,955,997 AtZYL BENZIR HDAZOLES AND METHOD OF PREPARING SAME Horace D. Brown, Plaintield, and Lewis H. Sarett, Princeton, Ni, assignors to Merck & Co., Inc, Rahway, N.J., a corporation of New Jersey No Drawing. Fiied Mar. 17, 1960, Ser. No. 15,518 9 Claims. (Cl. 260-402) This invention relates to new compounds useful against helminthiasis. It relates generally to new l-acyl benzimidazoles. More particularly, it relates to 1-acyl benzimidazoles having at the 2 position a heterocyclic radical containing nitrogen and sulfur. It is concerned also with methods of making such compounds from the corresponding unacylated benzimidazoles.
The infection known as helminthiasis involves infestation of the animal body, and particularly the gastrointestinal tract, with various species of parasitic worms. It is a very widespread and serious disease, and the methods heretofore available for its treatment and prevention have not been entirely satisfactory. It is an object of this invention to provide a group of substituted l-acyl benzimidazoles which are eifective in controlling helminthiasis, and which lack many of the objectionable features of the known anthelmintics.
According to the present invention, it has been found that benzimidazoles having an acyl radical at the 1 position of the benzimidazole ring nucleus and a heterocyclic radical containing nitrogen and sulfur at the 2 position thereof possess a significant degree of anthelmintic ac tivity and may be effectively employed in the treatment and/or prevention of helminthiasis. It is one object of the invention to provide such compounds. It is a more particular object to provide benzimidazoles substituted at the 1 position with an acyl radical and at the 2 position with a five-membered heterocyclic radical containing nitrogen and sulfur. A further object is provision of a method of synthesizing such compounds. Still other objects will become apparent from the following description of the invention.
The new compounds of our invention have the general structural formula the point of attachment to the benzimidazole nucleus may be at any one of the three carbon atoms of the heterocyclic ring, as indicated by the broken lines in the partial structures:
rt W N When R is a thiadiazolyl group containing two nitrogen atoms and one sulfur atom in the ring, the radical may be attached to the benzimidazole at either of the two groups at the 5 and/or 6 positions. the preferred substituents although ethyl, propyl and sim- 3,055,907 Patented Sept. 25, 1962 carbon atoms in a 1,2,3-thiadiazole or a 1,2,4-thiadiazole:
With the symmetrical thiadiazoles, i.e. 1,2,5-thiadiazole or 1,3,4-thiadiazole, only one point of attachment exists:
"1W NTN The heterocyclic radical may, if desired, be further substituted at a carbon atom with a lower hydrocarbon group such as a lower alkyl radical, the only limitation in this regard being that imposed by the availability of the substituted thiazoles, isothiazoles or thiadiazoles to be used as starting materials. 2-(2'-thiazolyl)-benzirnidazoles having a lower alkyl group at the 4 position of the thiazole ring and the 2-(5-isothiazolyl)-benzimidazoles having a lower alkyl group at the 3 position of the isothiazole ring such as 2-(4'methyl-2'-thiazolyl)-benzimidazole and 2 (3' methyl 5 isothiazolyl) benzimidazole are illustrative of this aspect of the invention.
The acyl substituent at the N-l position of the benzimidazole, which substituent is a critcal feature of the invention, may be a lower alkanoyl group (R C==O where R is lower alkyl) such as acetyl, propionyl, butyryl, valeryl and the like, an aroyl radical such as benzoyl or p-halobenzoyl, or an arallcanoyl substituent of the type illustrated by phenylacetyl. Thus R in Formula I above may be hydrocarbonyl radicals such as methyl, ethyl, propyl, butyl, phenyl, benzyl and phenylethyl. In the preferred embodiments of the invention the N-1 substituent is a lower alkanoyl group, and the 2 substituent is a Z-thiazolyl or 4-thi'azolyl radical.
If desired, the six-membered ring of the benzimidazole nucleus may also be substituted, as with lower alkyl Methyl groups are ilar lower alkyl radicals may, of course, be employed. The so-called pseudo-alkyl radicals, such as a trifluoromethyl substituent, may also be present at the 5 or 6 positions of the benzimidazole.
As representative of the novel substituted benzimidazole compounds falling within the scope of our invention and which may be prepared by the methods described hereinbelow, there may be mentioned l-acetyl-Z- (2' thiazolyl) benzimidazole, 1 acetyl 2 (4' thiazolyl) benzimidazole, 1 propionyl 2 (4' iso-thiazolyl) benzimidazole, 1 benzoyl 2 [4' ('1',2',3'- thiadiazolyl)] benzimidazole, 1 butyryl 2 [3' (1', 2',5 thiadiazolyl)] benzimidazole, 1 acetyl 2 [3'- (l,2,5 thiadiazolyl)] benzimidazole, 1 phenylacetyl 2 (2' thiazolyl) benzimidazole, 1 propionyl- 2 (4' thiazolyl) benzimidazole, l acetyl 2 [4- (1,2',3' thiadiazolyl)] 5,6 dimethyl benzimidazole, 1 acetyl 2 (4' thia'zolyl) 5 trifluoromethyl benzimidazole, 1 acetyl 2 (4' thiazolyl) -5,6 dimethyl benzimidazole and the like.
The 1 lower alkanoyl 2 thiazolyl benzimidazoles, wherein the point of attachment of the thiazolyl radical to the benzimidazole moiety is either the 2 or 4 position of the thiazole ring, represent the preferred compounds of the invention. These substances and the other l-acyl- 2-substituted benzimidazoles described herein are prepared by acylation of an alkali metal salt of a Z-R-benzimidazole as illustrated by the flow diagram:
where R is a five-membered heterocyclie radical containing nitrogen and sulfur, R is a hydrocarbonyl radical, R and R are hydrogen or lower alkyl (or pseudo-alkyl), M is an alkali metal and X is chlorine or bromine.
The process is carried out by first converting a 2-R- benzimidazole, where R is as above defined, to an alkali metal salt. It is preferred to form the sodium salt by reacting or intimately contacting the benzimidazole with sodium hydride in a suitable solvent medium. Satisfactory results are obtained when a slight molar excess of sodium hydride is employed, although equimolar quantities of benzimidazole and sodium hydride may be used if desired. The reaction is conveniently brought about by warming the reactants at slightly elevated temperatures, but this is not essential and room temperature is satisfactory.
The novel 1-acyl-2-R benzimidazoles of the invention are obtained by contacting the benzimidazole alkali metal salt with an acyl halide such as acetyl chloride, acetyl bromide, propionyl chloride, butyryl chloride, valeroyl bromide, benzoyl chloride, phenylacetyl chloride and the like. Normally, the acyl halide is added directly to a solution or suspension of the benzimidazole salt in an inert solvent, and the acylation reaction allowed to proceed at temperatures of room temperature up to about 100 C. Reaction temperatures in the range of 5075 C. are preferred. The solvent employed as the reaction medium is preferably a hydrocarbon solvent such as benzene, toluene, xylene, petroleum ether and the like either alone or mixed with other solvents miscible therewith such as dimethylformamide.
The l-acyl benzirnidazoles thus formed are recovered from the reaction mixture by techniques known in the art, such as removal of the organic solvent and crystallization of the residual solid from solvents such as ether or mixtures of ether with other solvents.
The 1-acyl-2-substituted benzimidazoles described herein have a high degree of anthelmintic activity with a low incidence of undesirable side effects. They are therefore useful in the treatment and/or prevention of helminthiasis, a parasitic disease which causes widespread and often serious infection in domesticated animals such as swine, ruminants such as cattle and sheep, and in man. The compounds of this invention are normally used, in treating helminthiasis, in unit dosage forms such as tablets, capsules, powders and the like wherein the active ingredient is intimately admixed with a suitable inert carrier. In treating domesticated animals, the compounds are mixed with a non-toxic edible carrier to form a feed supplement which is then incorporated in the animal feed in the desired concentration, or they may be administered in unit dosage forms which, in the case of large domesticated animals, take the form of boluses, or in the form of a liquid drench. Alternatively, water soluble salts or a dispersable, wettable powder containing the 2-heterocyclic benzimidazole may be added to the drinking water of the animals.
The following examples are given for the purpose of illustration and not by way of limitation:
EXAMPLE 1 1-Acetyl-2-(4'-Thiazolyl) -Benzimidazole g. (0.1 M) of 2-(4-thiazolyl)-benzimidazole is dissolved in a mixture of 500 ml. of toluene and 150 ml. of dimethylforrnamide. Traces of water are removed by distilling ml. of toluene from the mixture. 3.6 g. of sodium hydride (0.15 M) as a 50% emulsion in oil is suspended in 10 ml. of toluene and the mixture added to the benzimidazole solution at a temperature of about 60 C. The sodium hydride addition is carried out portionwise. The resulting mixture is stirred at 60 C. for one hour and at the end of this time 11.7 g. of acetyl chloride (0.15 M) is added dropwise at a temperature of 55-60 C. The mixture is refluxed gently for about 30 minutes, cooled on ice and 10 ml. of water added thereto. The resulting mixture is washed with two 50-ml. portions of 5% sodium bicarbonate solution and a small amount of solid is removed by filtration and the toluene solution concentrated to dryness in vacuo. The slightly yellow solid residue is recrystallized from ether to give 1 acetyl 2 (4 thiazolyl) benzimidazole, M.P. 134-136 C.
When this process is repeated employing 0.1 M of 2- (2' thiazolyl) benzimidazole or 2 [4 (1',2',3 thiadiazolyl)]-benzimidazole as the starting material, there is obtained respectively 1 acetyl 2 (2' thiazolyl)- benzimidazole and 1 acetyl 2 [4' (l,2',3 thiadiazolyl) ]-benzimidazole.
EXAMPLE 2 1-Benz0yl-2-(4-Thiaz0lyl) -Benzimidaz0le 20 g. of 2-(4-thiazolyl)-benzimidazole in a mixture of 400 ml. of benzene and 175 ml. of dimethylformamide is treated at 60 C. with 3.6 g. of sodium hydride. The sodium hydride is added as a 50% emulsion in oil mixed with 10 ml. of benzene. The addition is carried out slowly and the mixture heated with stirring at 60 C. for 45 minutes after completion of the sodium hydride addition. At the end of this time, 14 g. of benzoyl chloride is added slowly at a temperature of 60 C. and the resulting mixture heated for 40 minutes at that temperature and with stirring. The reaction mixture is then cooled to about 10 C., 15 ml. of water added and the entire mixture washed with 5% sodium bicarbonate solution. The organic solvent solution is filtered to remove any solid material and the benzene layer concentrated to dryness in vacuo. The residue is crystallized from ethyl ether to give substantially pure 1-benzoyl-2-(4-thiazolyl)-benzimidazole, M.P. 145 C.
EXAMPLE 3 1-Pr0pionyl-2-[3-(1',2',5'-Thiadiaz0lyl) -Benzimidaz0le 0.05 M of 2-[3-(1',2',5'-thiadiaz0lyl)]-benzimidazole in 400 ml. of benzene is treated with 1.8 g. of sodium hydride (52% emulsion in oil) in 5 ml. of benzene. The mixture is stirred at 40 C. for minutes. 4.6 g. of propionyl chloride are then added slowly with stirring of the reaction mixture. The mixture is then stirred at 50 C. for 40 minutes, cooled and 10 ml. of cold water added. The whole is washed with 5% sodium bicarbonate solution (2 x 50 ml.), filtered, and the benzene layer concentrated to dryness. The residual solid is crystallized from the minimum volume of ether to give substantially pure 1-propionyl-2-[3-(1',2,5'-thiadiaz0lyl)]-benzimidazole.
1-phenylacety1-2-(4-thiazolyl)-5-methyl benzimidazole and 1-phenylacetyl-2-(4-methyi-2-thiazolyl) benzimidazole are prepared in like fashion by reacting phenylacetyl bromide with 2-(4-thiazolyl)-5-methyl benzimidazole and 2-(4-methyl-2'-thiazo1yl)-benzimidazole respectively.
EXAMPLE 4 1-Acetyl-2-(4'-Is0thiaz0lyl) -Benzimidaz0le To 10 g. of 2-(4 isothiazolyl)-benzimidazole in 200 ml. of benzene and 70 ml. of dimethylformamide is added slowly with stirring 1.9 g. of sodium hydride (50% emulsion in oil) in 5 ml. of benzene. The mixture is stirred at 50 C. for 1 hour, and then 4 g. of acetyl chloride added slowly. The resulting mixture is refluxed gently for 30 minutes, then cooled and 10 ml. of water added to the cold reaction mixture. l-aeetyl-2-(4'-isothiazolyl)-benzimidnah...
, 3 azole is recovered in substantially pure form by the isolation method described in Example 1 above.
The 2-heterocyc1ic henzimidazoles employed as starting material in making the compounds of this invention are prepared by reacting together o-phenylenediamine and a heterocyclic earboxylic acid (Or derivative thereof) in polyphosphoric acid. The process is carried out at elevated temperatures, and preferably at temperatures of about 150-300 C. The optimum reaction time and temperature will, of course, depend to some extent on the particular reactants being employed, but in general good yields of the desired compounds are obtained by conducting the process at temperatures of about 175 to about 275 C. for from 2 to 6 hours. When the heterocyclic reactant is one that tends to decompose at elevated temperatures, e.g. 4-carboalkoxy-1,2,3-thiadiazole, it is helpful to preheat the reaction mixture at about 100-150 C. for a short period of time, and then to complete the reaction at the higher temperatures referred to above. The heterocyclic carboxylic acid itself may be used as one of the starting compounds or, alternatively, a lower alkyl ester or the amide of such acid may be employed. In cases where the free acid tends to decarboxylate at elevated temperatures, an amide or ester is used as the reactant for best results. For example, thiazole-Z-carboxamide is preferred over thiazole-Z-carboxylic acid as starting material in the synthesis of 2-(2'-thiazolyl)-benzimidazole since the free acid tends to decompose to thiazole itself at reaction temperature. It is preferred to employ substantially equimolar amounts of the heterocyclic compound and the diamine, and from about 20 parts by weight of polyphosphoric acid per part of heterocycle, although it will be appreciated by those skilled in this art that the relative amount of reactants is not a critical feature of the invention. The desired 2-substituted benzimidazoles are recovered by cooling the reaction mixture and diluting it with Water. Where the benzimidazoles do not crystallize readily under these conditions, they are precipitated by neutralizing the quenched mixture with a base such as ammonium hydroxide, an alkali metal hydroxide or an alkali metal carbonate. This synthesis of these new benzimidazoles, and the 2-substituted benzimidazoles produced thereby, are claimed in our copending application Serial No. 2,856, filed January 18, 1960, now Patent No. 3,017,415.
Examples illustrating the preparation of the Z-R-henzimidazoles, where R is a five-mem bered heterocyclic radical containing nitrogen and sulfur, follow:
(a) 2-(2-thiaz lyl)-benzimidaz0 le.-A mixture of 13.6 g. (.11 M) of thiazole-2-carboxamide, 11.5 g. (.11 M) of o-phenylenediamine and 272 g. of polyphosphoric acid is stirred and heated at 250 C. for 3%. hours. The reaction mixture is then cooled and poured into excess ice Water with stirring. The resulting red solution is filtered to remove a small amount of black insoluble material and then treated with decolorizing charcoal. The charcoal is removed by filtration, and the filtrate treated with 50% sodium hydroxide solution until just pink to phenolphthalein paper. The resulting precipitate is filtered oflt and washed with water. It is then dissolved in a minimum amount of boiling ethanol, treated With decolorizing charcoal, and the charcoal removed by filtration. Water is added to the boiling filtrate until its total volume is about 250 ml. 2-(2.-thiazolyl) benzimidazole crystallizes out immediately. The product is filtered, washed with cold 30% ethanol, and air dried, M.P. 245246 C.
(b) 2-(4'-lhiaz0lyl)-benzimidaz le.Tl1ree g. of thiazole-4-carboxylic acid hydrobromide (14.3 MM) and 2 g. of o-phenylenediamine (18.5 MM) are mixed and added to 60 g. of polyphosphoric acid. The mixture is 70 heated slowly with stirring to 240 C. and maintained at this temperature for 3 hours. The hot solution is then poured onto about 200 g. of ice. A taify-like mass separates which dissolves on stirring. The mixture is filtered and the filtrate neutralized with 30% sodium hydroxide.
At a pH of about 6, 2-(4'-thiazolyl)-benzimidazole pre cipitates. It is filtered, washed with water, and dried in air, M.P. 296-298 C.
This product is extracted with boiling ethanol. Some benzene is added to the extract and the solution boiled to remove traces of water. On concentration of the solution to a small volume and cooling, 2 -(4-thiazolyl)-benzirnidazole crystallizes, M.P. 301-302 C.
(c) 2-[4-(1,2',3-thiadiaz0lyl)] benzimidaz0le.-6.0 g. of 4-carbethoxy-1,2,3-thiadiazole and 8.0 g. of o-phenylenediamine are added to 120 g. of polyphosphoric acid preheated to about C. in a nitrogen atmosphere. After stirring for 1 hour at 125 C., the temperature is raised to 225 C. for 1 hour. The brown solution is cooled to about C. and poured (with stirring) in a thin stream into 200 cc. of cold water. A dark green amorphous solid is filtered off and the filtrate neutralized to pH ca. 7 with sodium hydroxide solution. The crystalline solid which precipitates is filtered, washed with water and dried. Extraction of this solid with several 200 ml. portions of acetone, treatment of the solution with Darco, filtration and removal of the solvent gives almost colorless crystals of 2-[4'-(1',2',3-thiadiazolyl)] benzimidazole, M.P. 2558 C.
(d) 2-[3-(J'-,2',5 thiadiazolylfl benzimidazola- 12.8 g. (0.081 M) of S-carbethoxy-1,2,5-thiadiazole, 11 g. (0.1 M) of o-phenylenediarnine and 50 g. of polyphosphoric acid are mixed and heated with stirring at 175 C. in a nitrogen atmosphere for 3 hours. At this time, the dark solution is cooled to about 100 C. and then slowly poured with stirring into about 500 m1. of cold water. The tacky threads slowly change to a brown solid. The suspension is neutralized to pH ca. 7 to precipitate the remainder of the product. The solid is washed with water, sodium bicarbonate solution to insure neutrality and dried in air. The 2-[3-(1',2',5-thiadiazolyl)]-benzimidazole is then recrystallized from ethyl acetate solution with a decolorizing charcoal treatment, M.P. 268-70 C. (sublimation 240). Recrystallization from ethyl acetate raises the M.P. to 272-274 C.
(e) 2-(4'-methyl-2'-thiazolyl) -benzimidaz0le.17 g. of 2-carbethoxy-4-1nethyl thiazole is added with stirring to 11 g. of o-phenylenediamine in g. of polyphosphoric acid. The resulting viscous mixture is heated slowly with stirring to about 125 C. and stirred at this tempera ture for 1 hour. The volatile material is allowed to escape through an air-cooled condenser. The temperature is then raised to 175 C. for 3 hours. At the end of this time, the reaction mixture is cooled and poured into excess ice water. The 2-(4'-methyl-2'athiazolyl)-benzimidazole is recovered according to the isolation procedure described in part (a) above.
2-(5-thiaz0lyl)-benzimidaz0le.13.2 g. of thiazole-S-canboxamide, 11.5 g. of o-phenylenedi-amine and 272 g. of polyphosphoric acid are reacted according to the procedure of part (a) above. The crude product is obtained is recrystallized from ethyl acetate to give substantially pure 2-(5-thiazolyl) -benzimidazole, M.P. 294- 195 C.
(g) 2-(4'-is0thiazolyl)-benzimidaz0le.-l5 g. of 4-carbethoxy isothiazole is added at room temperature to 11 g. of o-phenylenediamine in g. of polyphosphoric acid. The mixture is stirred and the temperature raised to 125 C. for 2 hours. It is then heated at C. for an additional 2 hours. The mixture is then poured into 1 liter of ice water and neutralized to a pH of about 6 with sodium hydroxide whereupon 2-(4-isothiazolyl)-benzimidazole precipitates. The product is filtered OE and extracted with hot acetone. The acetone extracts are treated with decolorizing charcoal and the filtrate obtained after removal of the charcoal is concentrated to dryness in vacuo to give the desired product, M.P. 319320 C.
75 of 3-methyl-5-carbomethoxy isothiazole are reacted with 7 22 g. of o-phenylenediamine in 175 g. of polyphosphoric acid according to the procedure set forth in part (g). There is obtained in this fashion 2-(3'-methyl-5-isothiazolyl -benzimidazo1e.
Any departure from the above description which conforms to the present invention is intended to be included within the scope of the claims.
What is claimed is:
1. A benzimidazole having the formula wherein R is a five-membered heterocyclic radical selected from the class consisting of thiazolyl, thiadi-azolyl and isothiazolyl rings wherein one carbon atom of said ring is attached to the benzimidazole ring, and the remaining car- References Cited in the file of this patent UNITED STATES PATENTS 2,483,392 Meyer et al Oct. 4, 1949

Claims (1)

1. A BENZIMIDAZOLE HAVING THE FORMULA
US15518A 1960-01-18 1960-03-17 Acyl benzimidazoles and method of preparing same Expired - Lifetime US3055907A (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
BE599143D BE599143A (en) 1960-01-18
US2856A US3017415A (en) 1960-01-18 1960-01-18 Certain benzimidazoles carrying thiazolyl, thiadiazolyl and isothiazolyl substituents in the 2 position
US15518A US3055907A (en) 1960-01-18 1960-03-17 Acyl benzimidazoles and method of preparing same
DEM45481A DE1235321B (en) 1960-01-18 1960-06-01 Process for the preparation of substituted benzimidazoles and their salts
GB20378/60A GB948635A (en) 1960-01-18 1960-06-09 Benzimidazole
ES0263822A ES263822A1 (en) 1960-01-18 1961-01-04 Certain benzimidazoles carrying thiazolyl, thiadiazolyl and isothiazolyl substituents in the 2 position
FR849060A FR1423609A (en) 1960-01-18 1961-01-06 Benzimidazole derivatives and their manufacturing process
CH1531665A CH423791A (en) 1960-01-18 1961-01-17 Process for the production of a benzimidazole
CH49061A CH423789A (en) 1960-01-18 1961-01-17 Process for the production of a benzimidazole
DK19761AA DK107167C (en) 1960-01-18 1961-01-17 Process for the preparation of benzimidazole compounds or acid addition salts thereof.
CH1531765A CH423792A (en) 1960-01-18 1961-01-17 Process for the preparation of 1-acyl-2-substituted benzimidazoles
CH1531565A CH423790A (en) 1960-01-18 1961-01-17 Process for the production of a benzimidazole
SE436/61A SE310883B (en) 1960-01-18 1961-01-17
CH1531865A CH423793A (en) 1960-01-18 1961-01-17 Process for the preparation of 1-alkyl and 1-alkenylbenzimidazoles
OA51102A OA00999A (en) 1960-01-18 1964-12-29 Benzimidazole derivatives and their manufacturing process.
CY30965A CY309A (en) 1960-01-18 1965-02-18 Benzinide
MY196575A MY6500075A (en) 1960-01-18 1965-12-31 Benzimidazoles
SE11797/67A SE320977B (en) 1960-01-18 1967-08-23

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2856A US3017415A (en) 1960-01-18 1960-01-18 Certain benzimidazoles carrying thiazolyl, thiadiazolyl and isothiazolyl substituents in the 2 position
US15518A US3055907A (en) 1960-01-18 1960-03-17 Acyl benzimidazoles and method of preparing same

Publications (1)

Publication Number Publication Date
US3055907A true US3055907A (en) 1962-09-25

Family

ID=26670973

Family Applications (2)

Application Number Title Priority Date Filing Date
US2856A Expired - Lifetime US3017415A (en) 1960-01-18 1960-01-18 Certain benzimidazoles carrying thiazolyl, thiadiazolyl and isothiazolyl substituents in the 2 position
US15518A Expired - Lifetime US3055907A (en) 1960-01-18 1960-03-17 Acyl benzimidazoles and method of preparing same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US2856A Expired - Lifetime US3017415A (en) 1960-01-18 1960-01-18 Certain benzimidazoles carrying thiazolyl, thiadiazolyl and isothiazolyl substituents in the 2 position

Country Status (12)

Country Link
US (2) US3017415A (en)
BE (1) BE599143A (en)
CH (5) CH423789A (en)
CY (1) CY309A (en)
DE (1) DE1235321B (en)
DK (1) DK107167C (en)
ES (1) ES263822A1 (en)
FR (1) FR1423609A (en)
GB (1) GB948635A (en)
MY (1) MY6500075A (en)
OA (1) OA00999A (en)
SE (2) SE310883B (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3183239A (en) * 1961-02-23 1965-05-11 Merck & Co Inc 5-ether and 5-thioether-2-heterocyclic benzimidazoles
US3299080A (en) * 1962-07-05 1967-01-17 Merck & Co Inc Processes and intermediates for preparing certain 2-thiazolylbenzimidazoles
DE1237731B (en) * 1963-05-23 1967-03-30 Merck & Co Inc Means to combat fungus growth
US3324102A (en) * 1963-01-31 1967-06-06 Merck & Co Inc Water-soluble benzimidazole-containing coordination compounds and methods relating thereto
US3471508A (en) * 1963-11-06 1969-10-07 Merck & Co Inc 5-aryl (or heteroaromatic) benzazoles
US3625954A (en) * 1968-03-20 1971-12-07 Pfizer 1-aroylbenzimidazoles
US3864351A (en) * 1971-10-04 1975-02-04 Pfizer 1-({60 -Carboxymethoxybenzoyl-2-(2{40 -pyridyl)benzimidazoles
US4017504A (en) * 1975-06-12 1977-04-12 Merck & Co., Inc. Antifungal 1-substituted benzimidazoles
US4017503A (en) * 1975-06-12 1977-04-12 Merck & Co., Inc. Antifungal 1-substituted benzimidazoles

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3239532A (en) * 1960-04-07 1966-03-08 Geigy Ag J R Certain diazolylmethyl esters of thiophosphoric and dithiophosphoric acids
GB1069937A (en) * 1963-06-24 1967-05-24 Merck & Co Inc N-(halopyruvoyl)-nitroanilides
IL22369A (en) * 1963-11-19 1968-10-24 Merck & Co Inc 2-heteroaryl-5 and/or 6-substituted benzazoles
GB1082355A (en) * 1963-11-29 1967-09-06 Merck & Co Inc Trifluoroacetoxy-alkenyl benzimidazoles
US3429890A (en) * 1964-12-31 1969-02-25 Merck & Co Inc Certain 2-thiazolylbenzimidazole-1-oxy derivatives
US3350211A (en) * 1964-12-31 1967-10-31 Merck & Co Inc Compositions useful in controlling marine fouling and methods for their use
BR6575771D0 (en) * 1964-12-31 1973-12-26 Merck & Co Inc PROCESS TO PREPARE BENZIMIDAZOLE 1-OXIDE
US3484519A (en) * 1965-12-02 1969-12-16 Merck & Co Inc Anthelmintic 2-substituted benzimidazole-metal arsenate compositions and method
US3475444A (en) * 1966-02-18 1969-10-28 Merck & Co Inc Complexes of 2-substituted benzimidazoles and bis-halogenated phenols
US3546341A (en) * 1966-02-18 1970-12-08 Merck & Co Inc Complexes of 2-substituted benzimidazoles and bis-halogenated phenols in anthelmintic compositions and methods
US3506678A (en) * 1967-02-21 1970-04-14 Merck & Co Inc Certain 2-substituted thieno(2,3-d) imidazoles
US3535331A (en) * 1967-07-26 1970-10-20 Merck & Co Inc Water-soluble 2-substituted benzimidazole hypophosphite salts
US3538108A (en) * 1967-08-17 1970-11-03 Merck & Co Inc Water - soluble 2 - substituted benzimidazole methanesulfonic acid salts
GB1221596A (en) * 1967-12-06 1971-02-03 Merck & Co Inc Benzimidazole derivatives
US3711608A (en) * 1971-04-13 1973-01-16 Merck & Co Inc The treatment of pain, fever and inflammation with benzimidazoles
US3899503A (en) * 1974-01-25 1975-08-12 Morton Norwich Products Inc Process for preparing 2-(2{40 )-furyl-, 2-(2{40 )-thienyl- 2-(4{40 )-thiazolyl- or 2-(2{40 )-pyrryl-5 (or 6) nitrobenzimidazole
US3998785A (en) * 1974-06-13 1976-12-21 International Business Machines Corporation Anti-fungal and/or anti-bacterial hardware for ink printing apparatus
US4006259A (en) * 1975-04-01 1977-02-01 Fmc Corporation Preservative coating for fruits and vegetables
JPS54127960A (en) * 1978-03-29 1979-10-04 Toray Silicone Co Ltd Organopolysiloxane composition
GB2176106A (en) * 1985-06-05 1986-12-17 Uniroyal Ltd Fungicides comprising carboxamidothiazoles
EP0236689A3 (en) * 1986-01-27 1988-04-27 Shell Internationale Researchmaatschappij B.V. Fungicidal compositions
US5013746A (en) * 1988-04-08 1991-05-07 Janssen Pharmaceutica N.V. Imazalil containing synergistic compositions
NZ232785A (en) * 1989-03-15 1991-03-26 Janssen Pharmaceutica Nv 5-(1,2 benzisoxazol-, benzimidazol and benzisothiazol-3- yl)-1h-benzimadazol-2-yl carbamic acid ester derivatives preparatory processes, intermediates and anthelmintic compositions
WO1990010630A1 (en) * 1989-03-15 1990-09-20 Janssen Pharmaceutica N.V. [5(6)-(benzisoxa-, benzisothia- or indazol-3-yl)-1h-benzimidazol-2-yl] carbamates
US5310924A (en) * 1993-04-30 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing thiabendazole
PL209203B1 (en) 2002-03-21 2011-08-31 Basf Ag Fungicide mixture, method for fighting harmful fungi and fungicide
WO2004047769A2 (en) * 2002-11-26 2004-06-10 Isis Pharmaceuticals, Inc. Benzimidazoles and analogs thereof as antibacterials
WO2004050035A2 (en) * 2002-12-03 2004-06-17 Isis Pharmaceuticals, Inc. Benzimidazoles and analogs thereof as antivirals
EP2489262B1 (en) 2006-09-18 2018-11-14 Basf Se Pesticidal mixtures comprising an anthranilamide insecticide and a fungicide
EP2164323A1 (en) 2006-12-15 2010-03-24 Rohm and Haas Company Mixtures comprising 1-methylcyclopropene
BR122019020355B1 (en) 2007-02-06 2020-08-18 Basf Se MIXTURES, PESTICIDE COMPOSITION, METHOD TO CONTROL HARMFUL PHYTOPATHOGENIC FUNGI, METHOD TO PROTECT PLANTS FROM ATTACK OR INFESTATION BY INSECTS, ACARIDES OR NEMATOSES AND METHOD TO PROTECT SEED
AU2008240710A1 (en) 2007-04-23 2008-10-30 Basf Se Plant productivity enhancement by combining chemical agents with transgenic modifications
AU2008303528B2 (en) 2007-09-26 2013-05-23 Basf Se Ternary fungicidal compositions comprising boscalid and chlorothalonil
US20090191138A1 (en) * 2008-01-30 2009-07-30 Mediquest Therapeutics, Inc. Novel topical formulations for improving the appearance of nails
EP2251010A1 (en) * 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Use of thiabendazole and derivatives thereof for the therapy of neurological conditions
WO2011026796A1 (en) 2009-09-01 2011-03-10 Basf Se Synergistic fungicidal mixtures comprising lactylates and method for combating phytopathogenic fungi
US20130267476A1 (en) 2010-12-20 2013-10-10 Basf Se Pesticidal Active Mixtures Comprising Pyrazole Compounds
EP2481284A3 (en) 2011-01-27 2012-10-17 Basf Se Pesticidal mixtures
EP3378313A1 (en) 2011-03-23 2018-09-26 Basf Se Compositions containing polymeric, ionic compounds comprising imidazolium groups
JP2014525424A (en) 2011-09-02 2014-09-29 ビーエーエスエフ ソシエタス・ヨーロピア Agricultural mixture containing arylquinazolinone compounds
CN102388909A (en) * 2011-10-13 2012-03-28 光华化学股份有限公司 Complex pesticide composition containing oxine-copper and thiabendazole
UA114913C2 (en) 2012-06-20 2017-08-28 Басф Се Pyrazole compound and pesticidal mixtures comprising a pyrazole compound
WO2014056780A1 (en) 2012-10-12 2014-04-17 Basf Se A method for combating phytopathogenic harmful microbes on cultivated plants or plant propagation material
PL2934147T3 (en) 2012-12-20 2020-06-29 BASF Agro B.V. Compositions comprising a triazole compound
EP2783569A1 (en) 2013-03-28 2014-10-01 Basf Se Compositions comprising a triazole compound
EP2835052A1 (en) 2013-08-07 2015-02-11 Basf Se Fungicidal mixtures comprising pyrimidine fungicides
WO2015036059A1 (en) 2013-09-16 2015-03-19 Basf Se Fungicidal pyrimidine compounds
WO2015036058A1 (en) 2013-09-16 2015-03-19 Basf Se Fungicidal pyrimidine compounds
EP2979549A1 (en) 2014-07-31 2016-02-03 Basf Se Method for improving the health of a plant
CN107075712A (en) 2014-10-24 2017-08-18 巴斯夫欧洲公司 Change solid particle surface charge non-both sexes, can quaternary and water-soluble polymer
BR112017028388B1 (en) 2015-07-02 2022-02-22 Basf Agro B.V COMPOSITION, USE OF A COMPOSITION, METHODS TO COMBAT PHYTOPATOGENIC FUNGI, DEPROTECTION OF SEEDS, ROOTS AND SPROUTS OF RESULTING PLANTS, CONTROL OF INSECTS, ACARIDES OR NEMATOIDS FOR PLANT PROTECTION AND IMPROVEMENT OF PLANT HEALTH AND USE OF A COMPOSITION

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2483392A (en) * 1949-10-04 Substituted ethylenes and process

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985661A (en) * 1956-02-06 1961-05-23 American Cyanamid Co Preparation of 2(omicron-aminophenyl)-benzimidazole

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2483392A (en) * 1949-10-04 Substituted ethylenes and process

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3183239A (en) * 1961-02-23 1965-05-11 Merck & Co Inc 5-ether and 5-thioether-2-heterocyclic benzimidazoles
US3299080A (en) * 1962-07-05 1967-01-17 Merck & Co Inc Processes and intermediates for preparing certain 2-thiazolylbenzimidazoles
US3324102A (en) * 1963-01-31 1967-06-06 Merck & Co Inc Water-soluble benzimidazole-containing coordination compounds and methods relating thereto
DE1237731B (en) * 1963-05-23 1967-03-30 Merck & Co Inc Means to combat fungus growth
US3471508A (en) * 1963-11-06 1969-10-07 Merck & Co Inc 5-aryl (or heteroaromatic) benzazoles
US3625954A (en) * 1968-03-20 1971-12-07 Pfizer 1-aroylbenzimidazoles
US3864351A (en) * 1971-10-04 1975-02-04 Pfizer 1-({60 -Carboxymethoxybenzoyl-2-(2{40 -pyridyl)benzimidazoles
US4017504A (en) * 1975-06-12 1977-04-12 Merck & Co., Inc. Antifungal 1-substituted benzimidazoles
US4017503A (en) * 1975-06-12 1977-04-12 Merck & Co., Inc. Antifungal 1-substituted benzimidazoles

Also Published As

Publication number Publication date
GB948635A (en) 1964-02-05
CH423790A (en) 1966-11-15
CH423791A (en) 1966-11-15
DK107167C (en) 1967-05-01
BE599143A (en)
CY309A (en) 1965-02-18
FR1423609A (en) 1966-01-07
CH423789A (en) 1966-11-15
US3017415A (en) 1962-01-16
SE320977B (en) 1970-02-23
CH423792A (en) 1966-11-15
CH423793A (en) 1966-11-15
ES263822A1 (en) 1961-05-16
SE310883B (en) 1969-05-19
OA00999A (en) 1968-08-07
MY6500075A (en) 1965-12-31
DE1235321B (en) 1967-03-02

Similar Documents

Publication Publication Date Title
US3055907A (en) Acyl benzimidazoles and method of preparing same
US3578671A (en) Oxazoles
US4444779A (en) Thiazolidine derivatives
US3274209A (en) Certain 6-substituted-imidazo[2, 1-b] thiazole compounds
KR910007976B1 (en) Process for preparations of thiazole derivatives
NO138422B (en) PROCEDURE AND SYSTEM FOR CALCINATION OF POWDERED MATERIAL CONTAINING LIME
IL22948A (en) 2-aryl-4(or 5)-nitroimidazoles and methods for their preparation
US3401173A (en) Heterocyclic acylaminobenzimidazoles
DE3884007T2 (en) Arylpiperazinylalkylenephenyl heterocyclic compounds.
US3476766A (en) Certain 2,4 - diarylthiazole-5-alkanoic acids and derivatives thereof
DK153950B (en) ANALOGY PROCEDURE FOR PREPARING QUINOLYLGUANIDIN OR DERIVATIVES THEREOF
US3759938A (en) Thiazolidine derivatives
US3336192A (en) Anthelmintic substituted benzimidazole compositions
US3274208A (en) Processes for preparing 2-thiazolylbenzimidazole compounds
US3897476A (en) Sulfamylbenzoic acid derivatives
PL101396B1 (en) METHOD OF PRODUCTION OF 2-CARBOALCOXYAMINOBENZIMIDAZOLYL-5/6 / -SULPHONIC ACID PHENYL ESTERS
US4090020A (en) Thienothiazine derivatives
US3183239A (en) 5-ether and 5-thioether-2-heterocyclic benzimidazoles
US3326753A (en) Benzimidazole anthelmintic compositions and method of use
US3471508A (en) 5-aryl (or heteroaromatic) benzazoles
AT237613B (en) Process for the preparation of new benzimidazole derivatives
US3138607A (en) Certain 2-(thio-azolyl)-benzazoles
GB2116975A (en) Guanidines
US3335052A (en) Anthelmintic composition and method of using same
GB1569238A (en) 2,5-dihdro-1,2-thiazino(5,6-b)indol-3-carboxamide-1,1-dioxide derivatives